Assessment of prevalence and characteristics of asthma-COPD overlap among patients with chronic airflow obstruction

Submitted: May 13, 2022
Accepted: August 7, 2022
Published: September 2, 2022
Abstract Views: 1231
PDF: 482
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


Given the paucity of research on asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) and the high prevalence of co-morbidities and healthcare utilization associated with it, the current study looked at the prevalence of ACO and its clinico-radiological phenotype in patients with chronic airflow obstruction. The study was conducted at a tertiary care hospital in North India. Patients over 40 with COPD or asthma were screened for inclusion in the ACO, asthma, and COPD groups. The ACO and COPD groups were further investigated. The clinical characteristics, lung functions, health-related quality of life, and radiological features of both groups were investigated and compared. ACO was discovered in 16.3% of patients with chronic airflow obstruction (asthma and COPD). The most commonly observed symptoms at presentation in the evaluated ACO patients (n=77) were shortness of breath, wheezing, cough, and expectoration (mean age at presentation: 57.9; mean duration of illness: 8.62 years). Exacerbation rates in ACO patients were significantly higher than in COPD patients (p<0.001). The ACO group had a significantly greater mean change in FEV1 post-bronchodilator in millilitres (ml) and percentage (379.61 ml and 37.72%) than the COPD group (p<0.001). The proportion of patients with emphysema was lower in the ACO group than in the COPD group (p<0.001). The ACO and COPD groups did not differ significantly in major airway wall thickness (p=0.3), but the COPD group had a significantly higher proportion of patients with vascular attenuation and distortion (p<0.001). Patients with COPD had a higher degree of hyperinflation, according to high resolution computed tomography (HRCT) indices. This study found that patients with ACO have a distinct phenotype in terms of clinical presentation and HRCT features. More research on the radiological features of ACO is required to identify the anatomical abnormalities involved in the disease's pathogenesis and to validate the radiological features of ACO.



PlumX Metrics


Download data is not yet available.


de Marco R, Pesce G, Marcon A, et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population. PloS One 2013;8:e62985. DOI:
Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532–55. DOI:
Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PloS Med 2006;3e442. DOI:
Koul PA. Chronic obstructive pulmonary disease: Indian guidelines and the road ahead. Lung India 2013;30:175–7. DOI:
To T, Stanojevic S, Moores G, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health 2012;12:204. DOI:
Koul PA, Patel D. Indian guidelines for asthma: Adherence is the key. Lung India 2015;32:S1-2. DOI:
Ehteshami-Afshar S, FitzGerald JM, Carlsten C, et al. The impact of comorbidities on productivity loss in asthma patients. Respir Res 2016;17:106. DOI:
Mukherjee M, Stoddart A, Gupta RP, et al. The epidemiology, healthcare and societal burden and costs of asthma in the UK and its member nations: analyses of standalone and linked national databases. BMC Med 2016;14:113. DOI:
Louie S, Zeki AA, Schivo M, Chan AL, et al. The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations. Expert Rev Clin Pharmacol 2013;6:197-219. DOI:
Soler-Cataluña JJ, Cosío B, Izquierdo JL, et al. Consensus document on the overlap phenotype COPD-asthma in COPD. Arch Bronconeumol 2012;48:331–7. DOI:
Hardin M, Cho M, McDonald ML, et al. The clinical and genetic features of COPD-asthma overlap syndrome. Eur Respir J 2014;44:341–50. DOI:
Menezes AMB, Montes de Oca M, Pérez-Padilla R, Nadeau G, Wehrmeister FC, Lopez-Varela MV, et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. Chest 2014;145:297–304. DOI:
Kraft M. Asthma and chronic obstructive pulmonary disease exhibit common origins in any country! Am J Respir Crit Care Med 2006;174:238–40. DOI:
Global Initiative for Asthma - GINA. 2017 Diagnosis and initial treatment of asthma, COPD and asthma-COPD overlap. Accessed 2022 Apr 2. Available from:
Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD assessment test. Eur Respir J 2009;34:648–54. DOI:
Reda AA, Kotz D, Kocks JWH, et al. Reliability and validity of the clinical COPD questionniare and chronic respiratory questionnaire. Respir Med 2010;104:1675–82. DOI:
Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005;26:319–38. DOI:
Andersén H, Lampela P, Nevanlinna A, et al. High hospital burden in overlap syndrome of asthma and COPD. Clin Respir J 2013;7:342–6. DOI:
Marsh SE, Travers J, Weatherall M, et al. Proportional classifications of COPD phenotypes. Thorax 2008;63:761–7. DOI:
Miravitlles M, Soriano JB, Ancochea J, et al. Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status. Respir Med 2013;107:1053–60. DOI:
Kauppi P, Kupiainen H, Lindqvist A, et al. Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma 2011;48:279–85. DOI:
Corlateanu A, Botnaru V, Rusu D, et al. Assessment of health-related quality of life in different phenotypes of COPD. Eur Respir J 2017;50:PA3581. DOI:
Cosentino J, Zhao H, Hardin M, et al. Analysis of asthma-chronic obstructive pulmonary disease overlap syndrome defined on the basis of bronchodilator response and degree of emphysema. Ann Am Thorac Soc 2016;13:1483–9. DOI:
Gao Y, Zhai X, Li K, et al. Asthma COPD Overlap syndrome on CT densitometry: A distinct phenotype from COPD. COPD 2016;13:471–6. DOI:
Suzuki T, Tada Y, Kawata N, et al. Clinical, physiological, and radiological features of asthma-chronic obstructive pulmonary disease overlap syndrome. Int J Chron Obstruct Pulmon Dis 2015;10:947–54. DOI:
Fayed HK, Abd-Elkareem YG, Samaha WA, Abdalshakour MS. Functional and radiological characteristics of asthma combined chronic obstructive pulmonary disease overlap. Egypt J Bronchol 2019;13:596–604. DOI:

How to Cite

Kumar, Kapil, Prem Parkash Gupta, Arvind Kumar Verma, and Rohtas Yadav. 2022. “Assessment of Prevalence and Characteristics of Asthma-COPD Overlap Among Patients With Chronic Airflow Obstruction”. Monaldi Archives for Chest Disease 93 (2).